| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.24B | -2.0% |
| Cost of Revenue | $4.55B | -1.3% |
| Gross Profit | $1.70B | -4.0% |
| R&D Expense | $109.0M | -1.8% |
| SG&A Expense | $960.0M | -1.4% |
| Operating Income | $547.0M | -10.5% |
| Pre-tax Income | $313.0M | -25.1% |
| Income Tax | $103.0M | -23.7% |
| Net Income | $210.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $636.0M | +95.1% |
| Accounts Receivable | $973.0M | -2.9% |
| Inventory | $941.0M | -3.5% |
| Current Assets | $2.74B | +9.6% |
| Total Assets | $6.64B | +4.0% |
| Current Liabilities | $1.52B | -1.4% |
| Long-term Debt | $1.42B | -0.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $440.0M | +189.5% |
| Capital Expenditures | $105.0M | +23.5% |
| Investing Cash Flow | -$44.0M | +94.2% |
| Financing Cash Flow | -$64.0M | -137.6% |
| Free Cash Flow | $335.0M | +400.0% |
| -25.8% |
| EPS (Basic) | $1.43 | -26.3% |
| EPS (Diluted) | $1.42 | -25.3% |
| Total Liabilities |
| $3.90B |
| +1.0% |
| Stockholders' Equity | $2.75B | +8.7% |